News Releases

June 15, 2020
HOOFDDORP, THE NETHERLANDS – June 15, 2020 – Bioventus , a global leader in orthobiologic solutions, has selected Bazis NN as its authorized distributor for DUROLANE , its single-injection joint-fluid osteoarthritis (OA) treatment. OA involves the breakdown, or degeneration, of cartilage and the
February 24, 2020
DURHAM, NC – February 24, 2020 – Bioventus , a global leader in orthobiologic solutions, is recognizing 25 years of proven bone healing with its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and
February 10, 2020
DURHAM, NC – February 10, 2020 – Bioventus , a global leader in orthobiologic solutions, has updated the indications for use for its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and promote
December 30, 2019
*** This is a test sample for BUSINESS WIRE quarterly results release style. It will need to be removed before the site is set to live. *** Revenues of $4.7 billion Free cash flow of $0.6 billion GAAP diluted loss per share of $0.24 Non-GAAP diluted EPS of $0.78 Restructuring plan on-track to
December 18, 2019
DURHAM, NC – December 18, 2019 – Beginning January 1, 2020 Bioventus , a global leader in orthobiologic solutions, has secured preferred access for Blue Cross Blue Shield of Michigan Medicare Advantage and Commercial patients to DUROLANE , GELSYN-3 and SUPARTZ FX to treat knee osteoarthritis (OA)
December 13, 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras porta, sapien a molestie rhoncus, odio lorem volutpat leo, at sollicitudin nisi lacus et quam. Morbi dignissim, magna vitae posuere semper, libero dolor pharetra diam, id venenatis nulla libero sed nibh. Etiam eu sapien odio.
Displaying 11 - 20 of 38